Search Results
Novel Investigational Drugs in AML What's the Data
Novel Agents Under Investigation for AML
How novel agents & individualized treatment approaches are improving outcomes in patients with AML
Novel agents in trials for AML: quizartinib and gilteritinib
Acute Myeloid Leukemia: Novel Therapies for Newly Diagnosed Patients - Part 1
Agents Under Investigation in AML
Novel investigational drugs and promising therapies for immune thrombocytopenia
MDS/AML Overlap and Novel Therapies with Dr. Naval Daver
Why MPNs Transform to AML
Novel combinations being explored in AML using an HMA-venetoclax backbone
Venetoclax & AML
Breakthrough Designation in AML, Application Submitted in Myeloma, Promising Data in SCLC, and More